TMO Thermo Fisher Scientific Inc.
Stable Earnings Power
B- 64.8 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
D+ 42
  • 5yr Avg ROIC 9.6%
  • Operating Margin Trend -1.73 pp/yr

Capital Efficiency

Weight: 15%
B+ 80
  • 5yr Avg ROE 14.6%
  • 5yr Share-Count CAGR -1.1%

Growth Quality

Weight: 15%
C+ 59
  • 5yr Revenue CAGR 6.7%
  • 5yr EPS CAGR 2.1%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 15%
A 91
  • 5yr FCF Margin 16.1%
  • 5yr FCF/NI Conversion 1.03x

Balance Sheet

Weight: 20%
B 71
  • Net Debt / EBITDA 2.55x
  • Interest Coverage (EBIT/Int) 6.12x
  • Altman Z-Score 4.00

Stability

Weight: 15%
C 52
  • EPS Volatility (σ/μ) 0.47
  • Negative-Revenue Years (5) 1/5
  • Piotroski F-Score 5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

6 of 6 gurus held; 1 new buy; 2 added; 2 trimmed; 2 full exits.

Holders
6
Avg Δ position
+7.5%
New buys
1
Full exits
2
As of Q2 2026